Omar Ishrak, chairperson of Intel and former CEO of Medtronic, will join the company’s board as it scales up digital therapeutics trials and care at home programs.
Category: healthcare
Centene Profits Hit $849 Million On Medicaid, Medicare And Obamacare Growth
Centene reported nearly $850 million in first quarter profit as membership grew by 1.9 million thanks to an increase in enrollment in Medicaid, Medicare and Obamacare plans, the company said Tuesday.
‘Ample Supply’: Biden Pushes Wider Use Of Pfizer’s Covid-Fighting Pill Paxlovid
The lifesaving antiviral pills are still underused despite an “ample supply,” the White House said.
With $35 Million In Funding, Waltz Health Aims To Lower Drug Prices Working With – Not Against – The System
Investors are banking industry veteran Mark Thierer and his data scientist son Jonathon can thread the needle.
Mental Health Startup Journey Colab Aims To Develop Mescaline As An FDA-Approved Treatment For Alcohol Use Disorder
Journey Colab will test mescaline, a long-acting psychedelic found in peyote, as an adjuvant to conventional treatments for alcohol use disorder. It gives co-founder equity to the Indigenous communities that inspire its work.
Physician Burnout Is Increasing, Gender Inequality Is Making It Worse
OB-GYNs and pediatricians have reported some of the medical profession’s largest increases in burnout over the past two years. This article examines an unwritten rule that explains this unfortunate trend.
Remote Health: Leaders Want To Open ‘Virtual Wards’ Across England
More and more patients look set to avoid a hospital stay as the country expands remote wards.
WHO: Mysterious Hepatitis Outbreak Has Led To One Child Dying, 17 Needing Liver Transplants
At least 169 children have developed hepatitis of unknown origin across 12 different countries.
FDA Approves First Covid Treatment For Children Under 12
The antiviral drug remdesivier is now approved for Covid-19 patients at least 28 days old.
Drug-Resistant Mold Increasingly Causing Serious Lung Infections
A new study from the U.K. has described drug-resistant lung infections in vulnerable people, raising concern that treatment options may be increasingly limited.
